249 related articles for article (PubMed ID: 9141425)
21. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2.
Bittencourt PL; Goldberg AC; Cançado EL; Porta G; Carrilho FJ; Farias AQ; Palacios SA; Chiarella JM; Abrantes-Lemos CP; Baggio VL; Laudanna AA; Kalil J
Am J Gastroenterol; 1999 Jul; 94(7):1906-13. PubMed ID: 10406258
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune reactions in HBV and HCV.
Michalska Z; Stalke P; Witczak-Malinowska K; Lakomy EA; Sikorska K; Radowska D; Stolarczyk J; Trocha H
Med Sci Monit; 2001 May; 7 Suppl 1():175-80. PubMed ID: 12211715
[TBL] [Abstract][Full Text] [Related]
23. Seroprevalence of AIH-related autoantibodies in patients with acute hepatitis E viral infection: a prospective case-control study in China.
Wu J; Guo N; Zhu L; Zhang X; Xiong C; Liu J; Xu Y; Fan J; Yu J; Pan Q; Yang J; Liang H; Jin X; Ye S; Wang W; Liu C; Zhang J; Li G; Jiang B; Cao H; Li L
Emerg Microbes Infect; 2020; 9(1):332-340. PubMed ID: 32037983
[TBL] [Abstract][Full Text] [Related]
24. Auto-antibodies in hepatitis C.
Zauli D; Cassani F; Bianchi FB
Biomed Pharmacother; 1999 Jun; 53(5-6):234-41. PubMed ID: 10424245
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of autoantibodies in autoimmune hepatitis.
Liberal R; Mieli-Vergani G; Vergani D
J Autoimmun; 2013 Oct; 46():17-24. PubMed ID: 24016388
[TBL] [Abstract][Full Text] [Related]
27. [Antibodies and physiopathogeny of autoimmune hepatitis].
García-Leiva J; Ríos-Vaca A; Torre-Delgadillo A
Rev Invest Clin; 2003; 55(5):577-82. PubMed ID: 14968479
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis.
Preda CM; Vermeire S; Rutgeerts P; Joosens S; Diculescu M; Marica C; Ciocarlan M; Mirea V; Oproiu A
Rom J Gastroenterol; 2005 Dec; 14(4):357-60. PubMed ID: 16400351
[TBL] [Abstract][Full Text] [Related]
29. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
Vidrich A; Lee J; James E; Cobb L; Targan S
J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune liver disease serology in acute hepatitis E virus infection.
Terziroli Beretta-Piccoli B; Ripellino P; Gobbi C; Cerny A; Baserga A; Di Bartolomeo C; Bihl F; Deleonardi G; Melidona L; Grondona AG; Mieli-Vergani G; Vergani D; Muratori L;
J Autoimmun; 2018 Nov; 94():1-6. PubMed ID: 30336842
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
33. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection.
Béland K; Lapierre P; Marceau G; Alvarez F
J Autoimmun; 2004 Mar; 22(2):159-66. PubMed ID: 14987745
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune hepatitis in India: profile of an uncommon disease.
Choudhuri G; Somani SK; Baba CS; Alexander G
BMC Gastroenterol; 2005 Aug; 5():27. PubMed ID: 16098234
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of autoantibodies in patients with endemic pemphigus foliaceus (fogo selvagem).
Nisihara RM; de Bem RS; Hausberger R; Roxo VS; Pavoni DP; Petzl-Erler ML; de Messias-Reason IJ
Arch Dermatol Res; 2003 Aug; 295(4):133-7. PubMed ID: 12844225
[TBL] [Abstract][Full Text] [Related]
36. Type 2 autoimmune hepatitis and hepatitis C viraemia.
Leri O; Paparo Barbaro S; Sinopoli MT; Marcelli V; De Rosa FG; De Luca D
Riv Eur Sci Med Farmacol; 1996; 18(1):3-6. PubMed ID: 8766775
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies and autoantigens in autoimmune hepatitis.
Strassburg CP; Manns MP
Semin Liver Dis; 2002 Nov; 22(4):339-52. PubMed ID: 12447706
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of anti-F-actin antibodies in a French multicenter study.
Chretien-Leprince P; Ballot E; Andre C; Olsson NO; Fabien N; Escande A; Oksman F; Dubuquoi S; Jego S; Goetz J; Chevailler A; Sanmarco M; Humbel RL; Johanet C
Ann N Y Acad Sci; 2005 Jun; 1050():266-73. PubMed ID: 16014542
[TBL] [Abstract][Full Text] [Related]
39. Serum immunological profile in patients with chronic autoimmune cholestasis.
Romero-Gómez M; Wichmann I; Crespo J; Parés A; Rodrigo L; Alvarez A; Diago M; Pons-Romero F; Sanchez-Munoz D; Aguilar-Reina J; Andrade RJ; Salmeron J; Sánchez-Pobre P; Rebollo JM; Martin-Vivaldi R; Castellano-Megias V; Nuñez-Roldan A; Bruguera M;
Am J Gastroenterol; 2004 Nov; 99(11):2150-7. PubMed ID: 15554996
[TBL] [Abstract][Full Text] [Related]
40. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.
Targan SR; Landers C; Vidrich A; Czaja AJ
Gastroenterology; 1995 Apr; 108(4):1159-66. PubMed ID: 7698584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
